RNA interference: from model organisms towards therapy for neural and neuromuscular disorders.
about
Reduction of mitoferrin results in abnormal development and extended lifespan in Caenorhabditis elegansSynthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive functionThe cys-loop ligand-gated ion channel gene superfamily of the red flour beetle, Tribolium castaneumManipulating insulin signaling to enhance mosquito reproduction.SiRNA Delivery with PEGylated Graphene Oxide Nanosheets for Combined Photothermal and Genetherapy for Pancreatic Cancer.Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection.Alzheimer's disease: insights from Drosophila melanogaster models.The small GTPase Rheb affects central brain neuronal morphology and memory formation in Drosophila.MicroRNA machinery responds to peripheral nerve lesion in an injury-regulated pattern.Chemistry-to-gene screens in Caenorhabditis elegans.The therapeutic potential of RNA interference.Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration.Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms.Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies.Gene silencing by RNAi in mouse Sertoli cellsImpaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity.Copper overload and deficiency both adversely affect the central nervous system of Drosophila.Functionalized MoS Nanosheets as Multi-Gene Delivery Vehicles for Pancreatic Cancer TherapyPolyglycerol-based amphiphilic dendrons as potential siRNA carriers for in vivo applications
P2860
Q27310363-B91B0A41-4D5D-47A2-A150-871564BC9BC2Q30448321-0539A37B-E289-442D-8342-D3C0F2DA7D96Q33299595-93EE0BC8-B7BE-4768-8BCC-A9C714B7BD29Q33495398-B9F9C913-687B-4319-BA81-5941379A3797Q33588169-FA1ACFDA-93CE-422E-B31E-9B7B24FD9993Q33694502-58B164D9-AE38-45FA-B6F7-DF520C027252Q33799241-7E57B6DE-6C63-4B39-AFDD-1CF08F94273CQ34427606-EBAE6B33-A90A-43F1-AF4F-8B9E0BE8AC3AQ35165082-C2A91E7F-CC7B-4481-A1A9-BBE3F6D00944Q36085676-82C4A1DB-61A7-4491-B402-8CF0F70A6383Q36237868-7E0790AF-517F-435E-ADD4-2B29835CEA2DQ36571516-DDC40A35-161B-4EDC-8020-915B5B49B88CQ37791489-5936A94E-4E58-4C32-AF18-D720270EC300Q38517896-13A407D1-B4A8-42B1-A649-80B42294FF91Q38542088-72070C36-AA11-415F-964B-3DBDE22C2220Q38639536-CF6B4BB4-DC4B-467C-89C0-C9549CF2387AQ40880975-49ED2B2D-4146-4166-97B1-2AED5609D14CQ41186950-D5EF858E-4A95-4E7B-ABC8-978F0C7BDFE7Q42703851-68A5D9BB-169A-4991-9BB8-FFECAEABFE12Q57495177-A8F0AFB9-28E6-476B-9AFD-5BBC704E3A3FQ58324580-3EB12268-345D-4535-8FC9-E0CA57D18A24
P2860
RNA interference: from model organisms towards therapy for neural and neuromuscular disorders.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
RNA interference: from model o ...... l and neuromuscular disorders.
@ast
RNA interference: from model o ...... l and neuromuscular disorders.
@en
type
label
RNA interference: from model o ...... l and neuromuscular disorders.
@ast
RNA interference: from model o ...... l and neuromuscular disorders.
@en
prefLabel
RNA interference: from model o ...... l and neuromuscular disorders.
@ast
RNA interference: from model o ...... l and neuromuscular disorders.
@en
P2093
P356
P1476
RNA interference: from model o ...... l and neuromuscular disorders.
@en
P2093
Behrooz Esmaeili
David B Sattelle
Matthew Wood
Steven D Buckingham
P304
P356
10.1093/HMG/DDH224
P478
13 Spec No 2
P577
2004-10-01T00:00:00Z